Telix Pharmaceuticals | TLX - 股票



金融业
股票价格
AUD 15.73
资产
AUD 1.36B
现金及等价物
AUD 141.87M
销售成本
AUD 245.71M
流动资产
AUD 488.02M
流动负债
AUD 242.34M
债务
AUD 467.11M
EBIT
AUD 46.36M
EBITDA
AUD 76.49M
EPS每股收益
AUD 0.1
股本和储备
AUD 408.17M
销售毛利
AUD 260.35M
债务利息支出
AUD 19.39M
利息收入
AUD 1.37M
贷款资金
AUD 564.44M
市值
AUD 5.1B
净收入
AUD 38.33M
营业费用
AUD 430.99M
营业利润
AUD 46.36M
普通股股本
AUD 339.79M
PE价格收益
223.36
税前利润
AUD 76.73M
销售收入
AUD 477.35M
销售和管理费用
AUD 107.02M
股票
AUD 37.08M
贸易债权人
AUD 168.97M
应收帐款人
AUD 170.39M


股票 更改 日
Cochlear AUD 499.4M 107.8M 2025-06
CSL USD 6.47B 327M 2025-06
Integral Diagnostics AUD 1.85M 2K 2023-12
Mayne Pharma AUD 74.63M 17.27M 2024-06
Medical Developments International AUD 9.45M 679K 2025-06
Mesoblast 21.66M 582K 2025-12
Pacific Edge NZD 1.01M 51K 2022-06
Polynovo AUD 8.97M 2.08M 2024-06
Ramsay Health Care AUD 404.4M 25M 2025-06
ResMed USD 911.88M 33.33M 2026-03
Sonic Healthcare AUD 208.83M 3.83M 2024-06